We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.54%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
+$188M
(+20%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
9.22%
Top 10 Holdings %
Top 10 Hldgs %
63.65%
Holding
34
New
7
Increased
11
Reduced
7
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$54.7M |
| 2 |
Labcorp
LH
|
+$49.6M |
| 3 |
AGN
Allergan Inc
AGN
|
+$43M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$32.7M |
| 5 |
SEM
Select Medical
SEM
|
+$27.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Community Health Systems
CYH
|
+$41.5M |
| 2 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$41.3M |
| 3 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
+$19.2M |
| 4 |
HNT
HEALTH NET INC
HNT
|
+$19M |
| 5 |
Elevance Health
ELV
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.71% |
| 2 | Consumer Discretionary | 2.15% |
| 3 | Financials | 1.02% |
| 4 | Industrials | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
DaVita
DVA
$15.2B
| $6.34M | 0.56% |
100,000
| – | – |
|
|
AH
27
DELISTED
Accretive Health
AH
| $3.21M | 0.28% |
+350,000
| New | +$3.01M |
|
28
Accuray
ARAY
$26.8M
| $1.74M | 0.15% |
+200,000
| New | +$1.55M |
|
|
29
Community Health Systems
CYH
$383M
| – | – |
-1,210,000
| Closed | -$41.5M |
|
|
WW
30
DELISTED
WW International
WW
| – | – |
-350,000
| Closed | -$13.1M |
|
|
HNT
31
DELISTED
HEALTH NET INC
HNT
| – | – |
-600,000
| Closed | -$19M |
|
|
VOLC
32
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| – | – |
-800,000
| Closed | -$19.2M |
|
|
ARTC
33
DELISTED
ARTHROCARE CORP
ARTC
| – | – |
-153,600
| Closed | -$5.46M |
|
|
WCRX
34
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| – | – |
-1,800,000
| Closed | -$41.3M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q4 2013 Portfolio in Review
As of Q4 2013, North Tide Capital held 34 positions worth $1.14B, up 20% from $953M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
North Tide Capital deployed $105M of net new capital in Q4 2013, opening 7 new positions and adding to 11 existing holdings. Its largest new stake was Labcorp: 582,000 shares worth $45.7M.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 65% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Elevance Health, an estimated $13.3M trimmed.
- North Tide Capital's largest Q4 2013 buy was Labcorp: 582,000 shares worth $45.7M.
- North Tide Capital added most to Allergan plc in Q4 2013, an estimated $54.7M increase.
- North Tide Capital's biggest Q4 2013 reduction was Elevance Health, cutting an estimated $13.3M.
- North Tide Capital fully exited Community Health Systems in Q4 2013, selling an estimated $41.5M.
- North Tide Capital's ten largest holdings make up 64% of its $1.14B portfolio in Q4 2013.
- North Tide Capital opened 7 new positions and closed 6 in Q4 2013.
- North Tide Capital's portfolio value rose 20% quarter-over-quarter to $1.14B.
Based on North Tide Capital's 13F filing for Q4 2013, filed 14 Feb 2014.